MARKET

DWTX

DWTX

Dogwood Therapeutics
NASDAQ
4.250
+0.070
+1.67%
After Hours: 4.240 -0.01 -0.24% 19:52 04/04 EDT
OPEN
3.820
PREV CLOSE
4.180
HIGH
4.340
LOW
3.820
VOLUME
95.84K
TURNOVER
--
52 WEEK HIGH
29.28
52 WEEK LOW
1.620
MARKET CAP
8.12M
P/E (TTM)
-0.6121
1D
5D
1M
3M
1Y
5Y
1D
Dogwood Therapeutics Announces Nasdaq Compliance Regained
NASDAQ · 3d ago
Dogwood regains Nasdaq compliance
TipRanks · 3d ago
BRIEF-Dogwood Therapeutics Regains Nasdaq Compliance
Reuters · 3d ago
Dogwood Therapeutics Reports 2024 Financial Results and Strategic Progress
TipRanks · 4d ago
*Dogwood Therapeutics 4Q Loss/Shr $6.29 >DWTX
Dow Jones · 6d ago
*Dogwood Therapeutics 4Q Rev $0.00 >DWTX
Dow Jones · 6d ago
Press Release: Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
Dow Jones · 6d ago
Press Release: Dogwood Therapeutics Announces -2-
Dow Jones · 6d ago
More
About DWTX
More
Dogwood Therapeutics, Inc., formerly Virios Therapeutics, Inc., is focused on the clinical development of three assets, Halneuron, IMC-1, and IMC-2. Halneuron is in Phase 2b development as a non-opioid, Nav 1.7 inhibitor, to treat the neuropathic pain associated with chemotherapy treatment. Halneuron is an injectable formulation of Tetrodotoxin, a novel small molecule with action exclusively on the peripheral nervous system. IMC-2 (valacyclovir + celecoxib) is in Phase 2 development as a combination antiviral treatment for Long-COVID (LC). IMC-1 (famciclovir (FM) + celecoxib) is Phase 3 development ready as a combination antiviral treatment for FM. IMC-1 has been granted fast track designation by the FDA. IMC-1 is a novel, proprietary, fixed dose combination of famciclovir and celecoxib designed to synergistically suppress herpes virus replication, with the end goal of reducing virally promoted disease symptoms.
Recently
Symbol
Price
%Change

Webull offers Dogwood Therapeutics Inc stock information, including NASDAQ: DWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DWTX stock methods without spending real money on the virtual paper trading platform.